{"slideshow_credits": null, "snippet": "Parents are fighting to keep a drug to treat autism and fragile X syndrome that failed clinical trials on the market because it has helped their children.", "abstract": "Parents are fighting to keep experimental drug arbaclofen, developed to treat autism and fragile X syndrome, on market after it failed in clinical trials, insisting that drug helped their children; developer Seaside Therapeutics claims it can no longer afford to supply drug to former trial participants.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/06/07/business/an-experimental-drugs-bitter-end.html", "lead_paragraph": "Parents are fighting to keep a drug to treat autism and fragile X syndrome that failed clinical trials on the market because it has helped their children.", "headline": {"main": "An Experimental Drug\u2019s Bitter End", "print_headline": "An Experimental Drug\u2019s Bitter End"}, "_id": "51b1356840e9ec65d203bc60", "word_count": "1524", "multimedia": [{"height": 126, "url": "images/2013/06/07/business/FRAGILE/FRAGILE-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/06/07/business/FRAGILE/FRAGILE-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 333, "url": "images/2013/06/07/business/FRAGILE/FRAGILE-articleLarge.jpg", "legacy": {"xlarge": "images/2013/06/07/business/FRAGILE/FRAGILE-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "333"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/06/07/business/FRAGILE/FRAGILE-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/06/07/business/FRAGILE/FRAGILE-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-06-07T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Clinical Trials", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Autism", "name": "subject", "is_major": "Y", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}